Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05750992

Ultrasound Guided TAPB vs Surgical TAPB With Bupivacaine in Cesarean Section

Ultrasound Guided Transversus Abdominis Plane Block (TAPB) vs Surgical TAPB With Bupivacaine for Acute Pain Control in Cesarean Section: A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
Female
Age
21 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare Surgical Transversus abdominis plane block and Ultrasound guided transversus abdominis plane block (TAPB) as a postoperative analgesic regimen in female patients undergoing elective cesarean delivery.

Detailed description

Caesarean delivery rates have been increasing worldwide nowadays. At rate of \[52%\], Egypt stands out among countries with the world's highest cesarean delivery percentages . Within the Arab region, rate of cesarean section far higher in Egypt than other Arab countries. A much simpler and theoretically superior means of establishing a TAP block. When using a transcutaneous (conventional) approach there is always the risk of peritoneal puncture with its attendant complications. Moreover, there are technical difficulties, especially in obese women and the procedure requires specialist equipment, a skilled operator and training in ultrasonography. Our approach obviates these risks and difficulties because the procedure is carried out under direct vision, and it is much easier to perform by the surgeon during caesarean section.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgical TAP blockperformed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally by the surgeon.
PROCEDUREUS guided TAP blockperformed by 40 ml of 0.25% bupivacaine (10 ml 0.5% bupivacaine bilaterally diluted with 10cc normal saline and 100 μg of fentanyl), the total volume was divided equally and administered bilaterally.

Timeline

Start date
2023-04-10
Primary completion
2026-12-30
Completion
2026-12-30
First posted
2023-03-02
Last updated
2026-01-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05750992. Inclusion in this directory is not an endorsement.